SUPN (STOCKS)
Supernus Pharmaceuticals, Inc.
$51.340000
+0.160000 (+0.31%)
Prev close: $51.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jack A. Khattar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,943.52M
- Employees
- 674
- P/E (TTM)
- -150.65
- P/B (TTM)
- 2.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $681.54M |
| Benefits Costs and Expenses | $702.27M |
| Cost Of Revenue | $77.65M |
| Costs And Expenses | $718.48M |
| Gross Profit | $603.89M |
| Nonoperating Income/Loss | $16.21M |
| Operating Expenses | $640.83M |
| Selling, General, and Administrative Expenses | $442.58M |
| Depreciation and Amortization | $2.20M |
| Research and Development | $107.06M |
| Other Operating Expenses | $88.99M |
| Operating Income/Loss | -$36.94M |
| Income/Loss From Continuing Operations After Tax | -$19.12M |
| Income/Loss From Continuing Operations Before Tax | -$20.73M |
| Income Tax Expense/Benefit | -$1.62M |
| Income Tax Expense/Benefit, Deferred | -$13.87M |
| Net Income/Loss | -$19.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.33 |
| Diluted Earnings Per Share | -$0.34 |
| Basic Average Shares | 56,256,782 |
| Diluted Average Shares | 56,301,270 |
| Assets | $1.42B |
| Current Assets | $593.89M |
| Inventory | $107.10M |
| Other Current Assets | $486.79M |
| Noncurrent Assets | $825.86M |
| Fixed Assets | $10.63M |
| Intangible Assets | $623.48M |
| Other Non-current Assets | $191.76M |
| Liabilities | $370.09M |
| Current Liabilities | $330.63M |
| Accounts Payable | $8.18M |
| Wages | $35.30M |
| Other Current Liabilities | $287.16M |
| Noncurrent Liabilities | $39.46M |
| Equity | $1.05B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.05B |
| Liabilities And Equity | $1.42B |
| Net Cash Flow From Operating Activities | $71.88M |
| Net Cash Flow From Operating Activities, Continuing | $71.88M |
| Net Cash Flow From Investing Activities | $42.78M |
| Net Cash Flow From Investing Activities, Continuing | $42.78M |
| Net Cash Flow From Financing Activities | $6.49M |
| Net Cash Flow From Financing Activities, Continuing | $6.49M |
| Net Cash Flow | $121.15M |
| Net Cash Flow, Continuing | $121.15M |
| Comprehensive Income/Loss | -$19.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.27M |
| Other Comprehensive Income/Loss | -$19.27M |
| Other Comprehensive Income/Loss Attributable To Parent | -$149.00K |